Spasticity & Movement Partners Opens in Englewood, New Jersey, Offering Specialized Care for Movement Disorders

Dr. David Park's new practice provides comprehensive, evidence-based care for spasticity and movement disorders, emphasizing personalized treatment and multidisciplinary collaboration to improve patient mobility and quality of life.

AI Industry News Staff
Healthcare
Spasticity & Movement Partners Opens in Englewood, New Jersey, Offering Specialized Care for Movement Disorders

Spasticity & Movement Partners, a specialty rehabilitation practice founded by Dr. David Park, has opened its doors in Englewood, New Jersey, at 15 Engle St, Suite 106. The practice aims to provide focused, compassionate, and evidence-based care for individuals living with spasticity and complex movement challenges, offering a personalized path forward for patients seeking to reduce pain, improve mobility, and regain confidence in daily life.

Spasticity can significantly impact daily activities such as walking, dressing, hygiene, and sleep, and can also affect caregivers. The practice addresses these challenges through comprehensive evaluation, advanced treatment options, and goal-based progress tracking. Dr. Park, a board-certified physiatrist with advanced training in physical medicine and rehabilitation, pain management, and spasticity-focused care, leads the team. He earned his medical degree from Boston University's accelerated BA/MD program, completed his residency at Tufts Medical Center, and pursued fellowship training in pain management in Manhattan.

“Spasticity care should never be one-size-fits-all,” said Dr. Park. “Every patient has a different story, different challenges, and different goals. My vision was to create a place where patients and caregivers receive clear answers, thoughtful treatment options, and a plan built around what matters most to them.”

The practice offers comprehensive spasticity assessments, including neurologic and musculoskeletal evaluation, range of motion testing, and gait observation. Treatment options include oral medications such as baclofen, tizanidine, and diazepam, as well as targeted procedures like botulinum toxin injections (Botox, Dysport, Xeomin, Myobloc), phenol nerve blocks, and diagnostic nerve blocks, often guided by ultrasound or electromyography. For severe spasticity, the practice provides intrathecal baclofen pump management, including refills and dose adjustments, in coordination with neurosurgical teams.

A defining feature of Spasticity & Movement Partners is its commitment to multidisciplinary collaboration. The practice works with physical and occupational therapists, neurologists, primary care physicians, and other specialists to ensure coordinated care. Treatment success is measured by functional improvements such as walking farther, transferring safely, and reducing pain, with regular reassessment to track progress.

The practice also recognizes the essential role of caregivers, offering education and a collaborative care model that respects their perspective. By involving caregivers as part of the team, the practice aims to improve communication and create treatment plans that fit the realities of home life.

Spasticity & Movement Partners enters the Northern New Jersey healthcare market with a vision to become a trusted leader in spasticity-focused rehabilitation, where personalized treatment meets innovation and clinical expertise pairs with empathy. For more information, visit www.spasticitymp.com or call 201-255-5552.

Blockchain Registration

QR Code for Blockchain Registration